Clinical Trial Update: Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes [NA]

View source ↗

Summary

A pilot study evaluated the safety and efficacy of 5-ALA-SFC in Type 2 diabetes; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• 5-ALA-SFC (5-aminolevulinic acid-sodium ferrous citrate)

Snippet

Sponsor: SBI Pharmaceuticals Co, Ltd. | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2017-12-11